Related Experiment Video
Updated: Jul 1, 2025

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate
Published on: October 31, 2012
Therapeutic potential of adipose derived stromal cells for major skin inflammatory diseases
Marina Ramírez Galera1, Jesper Svalgaard2, Anders Woetmann1
1The LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Abstract:
Inflammatory skin diseases like psoriasis and atopic dermatitis are chronic inflammatory skin conditions continuously under investigation due to increased prevalence and lack of cure. Moreover, long-term treatments available are often associated with adverse effects and drug resistance. Consequently, there is a clear unmet need for new therapeutic approaches. One promising and cutting-edge treatment option is the use of adipose-derived mesenchymal stromal cells (AD-MSCs) due to its immunomodulatory and anti-inflammatory properties. Therefore, this mini review aims to highlight why adipose-derived mesenchymal stromal cells are a potential new treatment for these diseases by summarizing the pre-clinical and clinical studies investigated up to date and addressing current limitations and unresolved clinical questions from a dermatological and immunomodulatory point of view.
Insights
Adipose-derived mesenchymal stromal cells (AD-MSCs) show promise for treating inflammatory skin diseases like psoriasis and atopic dermatitis. These cells offer immunomodulatory benefits, addressing limitations of current therapies.
Area of Science:
- Dermatology and Immunology
- Regenerative Medicine
Background:
- Psoriasis and atopic dermatitis are chronic inflammatory skin diseases with increasing prevalence.
- Current treatments have limitations including adverse effects and drug resistance, creating an unmet need for novel therapies.
Purpose of the Study:
- To review the potential of adipose-derived mesenchymal stromal cells (AD-MSCs) as a new therapeutic option for inflammatory skin conditions.
- To summarize preclinical and clinical evidence for AD-MSCs in dermatology.
- To address limitations and clinical questions regarding AD-MSC therapy.
Main Methods:
- Review of preclinical and clinical studies on adipose-derived mesenchymal stromal cells (AD-MSCs).
- Analysis of immunomodulatory and anti-inflammatory properties of AD-MSCs.
- Evaluation of dermatological applications and clinical data.
Main Results:
- Adipose-derived mesenchymal stromal cells (AD-MSCs) possess significant immunomodulatory and anti-inflammatory properties.
- Preclinical and clinical studies suggest potential efficacy for AD-MSCs in treating inflammatory skin diseases.
- Current research highlights AD-MSCs as a promising therapeutic avenue.
Conclusions:
- Adipose-derived mesenchymal stromal cells (AD-MSCs) represent a promising, cutting-edge treatment for chronic inflammatory skin diseases.
- Further research is needed to address limitations and unresolved clinical questions for widespread AD-MSC application in dermatology.
More Related Videos
11:00Isolation and Enrichment of Human Adipose-derived Stromal Cells for Enhanced Osteogenesis
Published on: January 12, 2015
06:56Author Spotlight: The Significance of Isolation, Culture, and Adipogenic Induction of SVF-Derived Preadipocytes from Mouse Perivascular Adipose Tissue
Published on: July 21, 2023
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Mesenchymal Stem Cells